Expression and function of interleukin-7 in secondary and tertiary lymphoid organs

Seminars in Immunology

Volumn 24, Issue 3, 2012, Pages 175-189

  Huang, Hsin Ying ^a   Luther, Sanjiv A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Fibroblastic reticular cells; IL 7 reporter mice; Lymph node; Lymph node development; Lymphoid tissue inducer cells; Spleen

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; CELL LINEAGE; CHRONIC INFLAMMATION; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; LYMPH NODE; LYMPHOID ORGAN; MEDICAL LITERATURE; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE;

ANIMALS; CELL LINEAGE; HOMEOSTASIS; HUMANS; INFLAMMATION; INTERLEUKIN-7; LYMPHATIC SYSTEM; RECEPTORS, INTERLEUKIN-7;

EID: 84862831203     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2012.02.008     Document Type: Review

References (229)

1. Namen A.E., Schmierer A.E., March C.J., Overell R.W., Park L.S., Urdal D.L., et al. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988, 167:988-1002.
2. Namen A.E., Lupton S., Hjerrild K., Wignall J., Mochizuki D.Y., Schmierer A., et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
3. Goodwin R.G., Friend D., Ziegler S.F., Jerzy R., Falk B.A., Gimpel S., et al. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 1990, 60:941-951.
4. Fry T.J., Mackall C.L. Interleukin-7: from bench to clinic. Blood 2002, 99:3892-3904.
5. Trinder P.K.E., Maeurer M.J. Interleukin-7. The cytokine handbook 2003, p. 305-45.
6. Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007, 7:144-154.
7. Kovanen P.E., Leonard W.J. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 2004, 202:67-83.
8. Hand T.W., Kaech S.M. Intrinsic and extrinsic control of effector T cell survival and memory T cell development. Immunol Res 2009, 45:46-61.
9. Surh C.D., Sprent J. Homeostasis of naive and memory T cells. Immunity 2008, 29:848-862.
10. Cui W., Kaech S.M. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev 2010, 236:151-166.
11. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005, 16:513-533.
12. Mackall C.L., Fry T.J., Gress R.E. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011, 11:330-342.
13. Vogt T.K., Link A., Perrin J., Finke D., Luther S.A. Novel function for interleukin-7 in dendritic cell development. Blood 2009, 113:3961-3968.
14. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2010, 12:21-27.
15. Kroncke R., Loppnow H., Flad H.D., Gerdes J. Human follicular dendritic cells and vascular cells produce interleukin-7: a potential role for interleukin-7 in the germinal center reaction. Eur J Immunol 1996, 26:2541-2544.
16. Dus D., Krawczenko A., Zalecki P., Paprocka M., Wiedlocha A., Goupille C., et al. IL-7 receptor is present on human microvascular endothelial cells. Immunol Lett 2003, 86:163-168.
17. Michaelson M.D., Mehler M.F., Xu H., Gross R.E., Kessler J.A. Interleukin-7 is trophic for embryonic neurons and is expressed in developing brain. Dev Biol 1996, 179:251-263.
18. Moors M., Vudattu N.K., Abel J., Kramer U., Rane L., Ulfig N., et al. Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells. Genes Immun 2010, 11:11-20.
19. Iwanami N., Mateos F., Hess I., Riffel N., Soza-Ried C., Schorpp M., et al. Genetic evidence for an evolutionarily conserved role of IL-7 signaling in T cell development of zebrafish. J Immunol 2011, 186:7060-7066.
20. Lane P., Kim M.Y., Withers D., Gaspal F., Bekiaris V., Desanti G., et al. Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses. Semin Immunol 2008, 20:159-163.
21. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010, 11:289-293.
22. Liu Y.J., Soumelis V., Watanabe N., Ito T., Wang Y.H., Malefyt Rde W., et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007, 25:193-219.
23. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
24. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526.
25. DiSanto J.P., Muller W., Guy-Grand D., Fischer A., Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 1995, 92:377-381.
26. He Y.W., Malek T.R. Interleukin-7 receptor alpha is essential for the development of gamma delta+ T cells, but not natural killer cells. J Exp Med 1996, 184:289-293.
27. Maki K., Sunaga S., Komagata Y., Kodaira Y., Mabuchi A., Karasuyama H., et al. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc Natl Acad Sci U S A 1996, 93:7172-7177.
28. Park S.Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995, 3:771-782.
29. Al-Shami A., Spolski R., Kelly J., Fry T., Schwartzberg P.L., Pandey A., et al. A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med 2004, 200:159-168.
30. Carpino N., Thierfelder W.E., Chang M.S., Saris C., Turner S.J., Ziegler S.F., et al. Absence of an essential role for thymic stromal lymphopoietin receptor in murine B-cell development. Mol Cell Biol 2004, 24:2584-2592.
31. Peffault de Latour R., Dujardin H.C., Mishellany F., Burlen-Defranoux O., Zuber J., Marques R., et al. Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. Blood 2006, 108:2300-2306.
32. Mazzucchelli R., Hixon J.A., Spolski R., Chen X., Li W.Q., Hall V.L., et al. Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP. Blood 2008, 112:3283-3292.
33. Simonetta F., Chiali A., Cordier C., Urrutia A., Girault I., Bloquet S., et al. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur J Immunol 2010, 40:2528-2538.
34. Sudo T., Nishikawa S., Ohno N., Akiyama N., Tamakoshi M., Yoshida H. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A 1993, 90:9125-9129.
35. Carvalho T.L., Mota-Santos T., Cumano A., Demengeot J., Vieira P. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7 -/- mice. J Exp Med 2001, 194:1141-1150.
36. Erlandsson L., Licence S., Gaspal F., Bell S., Lane P., Corcoran A.E., et al. Impaired B-1 and B-2 B cell development and atypical splenic B cell structures in IL-7 receptor-deficient mice. Eur J Immunol 2004, 34:3595-3603.
37. Jensen C.T., Kharazi S., Boiers C., Cheng M., Lubking A., Sitnicka E., et al. FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis. Blood 2008, 112:2297-2304.
38. Zhou B., Comeau M.R., De Smedt T., Liggitt H.D., Dahl M.E., Lewis D.B., et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005, 6:1047-1053.
39. Lu N., Wang Y.H., Arima K., Hanabuchi S., Liu Y.J. TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis. J Exp Med 2009, 206:2111-2119.
40. Yang G.X., Lian Z.X., Kikuchi K., Moritoki Y., Ansari A.A., Liu Y.J., et al. Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors. J Immunol 2005, 175:7281-7287.
41. Esashi E., Wang Y.H., Perng O., Qin X.F., Liu Y.J., Watowich S.S. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 2008, 28:509-520.
42. Takeuchi S., Katz S.I. Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells. Blood 2006, 107:184-186.
43. Shigematsu H., Reizis B., Iwasaki H., Mizuno S., Hu D., Traver D., et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 2004, 21:43-53.
44. Schlenner S.M., Madan V., Busch K., Tietz A., Laufle C., Costa C., et al. Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 2010, 32:426-436.
45. Larregina A.T., Morelli A.E., Kolkowski E., Sanjuan N., Barboza M.E., Fainboim L. Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants. Immunology 1997, 91:303-313.
46. Li L., Masucci M.G., Levitsky V. Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells. Scand J Immunol 2000, 51:361-371.
47. Tureci O., Ding J., Hilton H., Bian H., Ohkawa H., Braxenthaler M., et al. Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles. FASEB J 2003, 17:376-385.
48. Messmer D., Messmer B., Chiorazzi N. The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. Int Immunol 2003, 15:491-503.
49. Roozendaal R., Mebius R.E. Stromal cell-immune cell interactions. Annu Rev Immunol 2011, 29:23-43.
50. Randall T.D., Carragher D.M., Rangel-Moreno J. Development of secondary lymphoid organs. Annu Rev Immunol 2008, 26:627-650.
51. Luther S.A., Ansel K.M., Cyster J.G. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med 2003, 197:1191-1198.
52. Meier D., Bornmann C., Chappaz S., Schmutz S., Otten L.A., Ceredig R., et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007, 26:643-654.
53. Schmutz S., Bosco N., Chappaz S., Boyman O., Acha-Orbea H., Ceredig R., et al. Cutting edge: IL-7 regulates the peripheral pool of adult ROR gamma+ lymphoid tissue inducer cells. J Immunol 2009, 183:2217-2221.
54. Lane P.J., Gaspal F.M., Kim M.Y. Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization. Nat Rev Immunol 2005, 5:655-660.
55. Chappaz S., Finke D. The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes. J Immunol 2010, 184:3562-3569.
56. Hou T.Z., Mustafa M.Z., Flavell S.J., Barrington F., Jenkinson E.J., Anderson G., et al. Splenic stromal cells mediate IL-7 independent adult lymphoid tissue inducer cell survival. Eur J Immunol 2010, 40:359-365.
57. Chappaz S., Gartner C., Rodewald H.R., Finke D. Kit ligand and Il7 differentially regulate Peyer's patch and lymph node development. J Immunol 2010, 185:3514-3519.
58. Vivier E., Spits H., Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair. Nat Rev Immunol 2009, 9:229-234.
59. Vonarbourg C., Mortha A., Bui V.L., Hernandez P.P., Kiss E.A., Hoyler T., et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 2010, 33:736-751.
60. Cella M., Otero K., Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A 2010, 107:10961-10966.
61. Puel A., Ziegler S.F., Buckley R.H., Leonard W.J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998, 20:394-397.
62. Noguchi M., Yi H., Rosenblatt H.M., Filipovich A.H., Adelstein S., Modi W.S., et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157.
63. Nishikawa S., Honda K., Vieira P., Yoshida H. Organogenesis of peripheral lymphoid organs. Immunol Rev 2003, 195:72-80.
64. Okuda M., Togawa A., Wada H., Nishikawa S. Distinct activities of stromal cells involved in the organogenesis of lymph nodes and Peyer's patches. J Immunol 2007, 179:804-811.
65. Peduto L., Dulauroy S., Lochner M., Spath G.F., Morales M.A., Cumano A., et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol 2009, 182:5789-5799.
66. Benezech C., White A., Mader E., Serre K., Parnell S., Pfeffer K., et al. Ontogeny of stromal organizer cells during lymph node development. J Immunol 2010, 184:4521-4530.
67. Yoshida H., Honda K., Shinkura R., Adachi S., Nishikawa S., Maki K., et al. IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int Immunol 1999, 11:643-655.
68. Yoshida H., Naito A., Inoue J., Satoh M., Santee-Cooper S.M., Ware C.F., et al. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002, 17:823-833.
69. Honda K., Nakano H., Yoshida H., Nishikawa S., Rennert P., Ikuta K., et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J Exp Med 2001, 193:621-630.
70. Vondenhoff M.F., Greuter M., Goverse G., Elewaut D., Dewint P., Ware C.F., et al. LTbetaR signaling induces cytokine expression and up-regulates lymphangiogenic factors in lymph node anlagen. J Immunol 2009, 182:5439-5445.
71. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009, 10:66-74.
72. Coles M.C., Veiga-Fernandes H., Foster K.E., Norton T., Pagakis S.N., Seddon B., et al. Role of T and NK cells and IL7/IL7r interactions during neonatal maturation of lymph nodes. Proc Natl Acad Sci U S A 2006, 103:13457-13462.
73. Browning J.L., Allaire N., Ngam-Ek A., Notidis E., Hunt J., Perrin S., et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 2005, 23:539-550.
74. Ngo V.N., Cornall R.J., Cyster J.G. Splenic T zone development is B cell dependent. J Exp Med 2001, 194:1649-1660.
75. Kim D., Mebius R.E., MacMicking J.D., Jung S., Cupedo T., Castellanos Y., et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 2000, 192:1467-1478.
76. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
77. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999, 13:2412-2424.
78. Cupedo T., Vondenhoff M.F., Heeregrave E.J., De Weerd A.E., Jansen W., Jackson D.G., et al. Presumptive lymph node organizers are differentially represented in developing mesenteric and peripheral nodes. J Immunol 2004, 173:2968-2975.
79. Fukuyama S., Hiroi T., Yokota Y., Rennert P.D., Yanagita M., Kinoshita N., et al. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells. Immunity 2002, 17:31-40.
80. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000, 288:2369-2373.
81. Harmsen A., Kusser K., Hartson L., Tighe M., Sunshine M.J., Sedgwick J.D., et al. Cutting edge: organogenesis of nasal-associated lymphoid tissue (NALT) occurs independently of lymphotoxin-alpha (LT alpha) and retinoic acid receptor-related orphan receptor-gamma, but the organization of NALT is LT alpha dependent. J Immunol 2002, 168:986-990.
82. Junt T., Scandella E., Ludewig B. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 2008, 8:764-775.
83. Mueller S.N., Germain R.N. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009, 9:618-629.
84. Allen C.D., Cyster J.G. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol 2008, 20:14-25.
85. Kosco-Vilbois M.H. Are follicular dendritic cells really good for nothing. Nat Rev Immunol 2003, 3:764-769.
86. Gretz J.E., Anderson A.O., Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 1997, 156:11-24.
87. Katakai T., Hara T., Sugai M., Gonda H., Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med 2004, 200:783-795.
88. Link A., Vogt T.K., Favre S., Britschgi M.R., Acha-Orbea H., Hinz B., et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007, 8:1255-1265.
89. Forster R., Davalos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008, 8:362-371.
90. Katakai T., Suto H., Sugai M., Gonda H., Togawa A., Suematsu S., et al. Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. J Immunol 2008, 181:6189-6200.
91. Guimond M., Veenstra R.G., Grindler D.J., Zhang H., Cui Y., Murphy R.D., et al. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol 2009, 10:149-157.
92. Mazzucchelli R.I., Warming S., Lawrence S.M., Ishii M., Abshari M., Washington A.V., et al. Visualization and identification of IL-7 producing cells in reporter mice. PLoS ONE 2009, 4:e7637.
93. Zeng M., Smith A.J., Wietgrefe S.W., Southern P.J., Schacker T.W., Reilly C.S., et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest 2011, 121:998-1008.
94. Carreno B.M., Becker-Hapak M., Linette G.P. CD40 regulates human dendritic cell-derived IL-7 production that, in turn, contributes to CD8(+) T-cell antigen-specific expansion. Immunol Cell Biol 2009, 87:167-177.
95. Sorg R.V., McLellan A.D., Hock B.D., Fearnley D.B., Hart D.N. Human dendritic cells express functional interleukin-7. Immunobiology 1998, 198:514-526.
96. de Saint-Vis B., Fugier-Vivier I., Massacrier C., Gaillard C., Vanbervliet B., Ait-Yahia S., et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998, 160:1666-1676.
97. Funk P.E., Stephan R.P., Witte P.L. Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow. Blood 1995, 86:2661-2671.
98. Tokoyoda K., Egawa T., Sugiyama T., Choi B.I., Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
99. Kitazawa H., Muegge K., Badolato R., Wang J.M., Fogler W.E., Ferris D.K., et al. IL-7 activates alpha4beta1 integrin in murine thymocytes. J Immunol 1997, 159:2259-2264.
100. Wiles M.V., Ruiz P., Imhof B.A. Interleukin-7 expression during mouse thymus development. Eur J Immunol 1992, 22:1037-1042.
101. Shalapour S., Deiser K., Sercan O., Tuckermann J., Minnich K., Willimsky G., et al. Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo. Eur J Immunol 2010, 40:2391-2400.
102. Hikida M., Nakayama Y., Yamashita Y., Kumazawa Y., Nishikawa S.I., Ohmori H. Expression of recombination activating genes in germinal center B cells: involvement of interleukin 7 (IL-7) and the IL-7 receptor. J Exp Med 1998, 188:365-372.
103. Bebo B.F., Schuster J.C., Adlard K., Vandenbark A.A., Offner H. Interleukin 7 is a potent co-stimulator of myelin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis. Cytokine 2000, 12:324-331.
104. Wallace D.L., Berard M., Soares M.V., Oldham J., Cook J.E., Akbar A.N., et al. Prolonged exposure of naive CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 2006, 119:243-253.
105. Ariel A., Hershkoviz R., Cahalon L., Williams D.E., Akiyama S.K., Yamada K.M., et al. Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix-bound interleukin-7. Eur J Immunol 1997, 27:2562-2570.
106. Banwell C.M., Partington K.M., Jenkinson E.J., Anderson G. Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur J Immunol 2000, 30:2125-2129.
107. Henriques C.M., Rino J., Nibbs R.J., Graham G.J., Barata J.T. IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells. Blood 2010, 115:3269-3277.
108. Alves N.L., Richard-Le Goff O., Huntington N.D., Sousa A.P., Ribeiro V.S., Bordack A., et al. Characterization of the thymic IL-7 niche in vivo. Proc Natl Acad Sci U S A 2009, 106:1512-1517.
109. Repass J.F., Laurent M.N., Carter C., Reizis B., Bedford M.T., Cardenas K., et al. IL7-hCD25 and IL7-Cre BAC transgenic mouse lines: new tools for analysis of IL-7 expressing cells. Genesis 2009, 47:281-287.
110. Kim G.Y., Hong C., Park J.H. Seeing is believing: illuminating the source of in vivo interleukin-7. Immune Netw 2011, 11:1-10.
111. Moore N.C., Anderson G., Smith C.A., Owen J.J., Jenkinson E.J. Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction. Eur J Immunol 1993, 23:922-927.
112. Oosterwegel M.A., Haks M.C., Jeffry U., Murray R., Kruisbeek A.M. Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells. Immunity 1997, 6:351-360.
113. Golden-Mason L., Kelly A.M., Traynor O., McEntee G., Kelly J., Hegarty J.E., et al. Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver: implications for extrathymic T cell development. Cytokine 2001, 14:143-151.
114. Trinder P., Seitzer U., Gerdes J., Seliger B., Maeurer M. Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int J Oncol 1999, 14:23-31.
115. Mohrs M., Shinkai K., Mohrs K., Locksley R.M. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 2001, 15:303-311.
116. Alves N.L., Huntington N.D., Mention J.J., Richard-Le Goff O., Di Santo J.P. Cutting edge: a thymocyte-thymic epithelial cell cross-talk dynamically regulates intrathymic IL-7 expression in vivo. J Immunol 2010, 184:5949-5953.
117. Oshima S., Nakamura T., Namiki S., Okada E., Tsuchiya K., Okamoto R., et al. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells. Mol Cell Biol 2004, 24:6298-6310.
118. Lee H.W., Na Y.J., Jung P.K., Kim M.N., Kim S.M., Chung J.S., et al. Nerve growth factor stimulates proliferation, adhesion and thymopoietic cytokine expression in mouse thymic epithelial cells in vitro. Regul Pept 2008, 147:72-81.
119. Harada S., Yamamura M., Okamoto H., Morita Y., Kawashima M., Aita T., et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 1999, 42:1508-1516.
120. Sawa S., Kamimura D., Jin G.H., Morikawa H., Kamon H., Nishihara M., et al. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med 2006, 203:1459-1470.
121. Yoshioka A., Okamoto R., Oshima S., Akiyama J., Tsuchiya K., Nakamura T., et al. Flagellin stimulation suppresses IL-7 secretion of intestinal epithelial cells. Cytokine 2008, 44:57-64.
122. Thang P.H., Ruffin N., Brodin D., Rethi B., Cam P.D., Hien N.T., et al. The role of IL-1beta in reduced IL-7 production by stromal and epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1 infection. J Intern Med 2010, 268:181-193.
123. Tang J., Nuccie B.L., Ritterman I., Liesveld J.L., Abboud C.N., Ryan D.H. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol 1997, 159:117-125.
124. Sawa Y., Arima Y., Ogura H., Kitabayashi C., Jiang J.J., Fukushima T., et al. Hepatic interleukin-7 expression regulates T cell responses. Immunity 2009, 30:447-457.
125. Kilroy G.E., Foster S.J., Wu X., Ruiz J., Sherwood S., Heifetz A., et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007, 212:702-709.
126. Takada K., Jameson S.C. Naive T cell homeostasis: from awareness of space to a sense of place. Nat Rev Immunol 2009, 9:823-832.
127. Bachmann M.F., Wolint P., Schwarz K., Jager P., Oxenius A. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol 2005, 175:4686-4696.
128. Huster K.M., Busch V., Schiemann M., Linkemann K., Kerksiek K.M., Wagner H., et al. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A 2004, 101:5610-5615.
129. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
130. Schluns K.S., Kieper W.C., Jameson S.C., Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000, 1:426-432.
131. Franchimont D., Galon J., Vacchio M.S., Fan S., Visconti R., Frucht D.M., et al. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J Immunol 2002, 168:2212-2218.
132. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003, 4:1191-1198.
133. Park J.H., Yu Q., Erman B., Appelbaum J.S., Montoya-Durango D., Grimes H.L., et al. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 2004, 21:289-302.
134. Moniuszko M., Fry T., Tsai W.P., Morre M., Assouline B., Cortez P., et al. Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol 2004, 78:9740-9749.
135. Marrack P., Kappler J. Control of T cell viability. Annu Rev Immunol 2004, 22:765-787.
136. Grandjean I., Duban L., Bonney E.A., Corcuff E., Di Santo J.P., Matzinger P., et al. Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells. J Exp Med 2003, 198:1089-1102.
137. Maraskovsky E., O'Reilly L.A., Teepe M., Corcoran L.M., Peschon J.J., Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997, 89:1011-1019.
138. Pellegrini M., Bouillet P., Robati M., Belz G.T., Davey G.M., Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004, 200:1189-1195.
139. Wojciechowski S., Tripathi P., Bourdeau T., Acero L., Grimes H.L., Katz J.D., et al. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med 2007, 204:1665-1675.
140. Rathmell J.C., Farkash E.A., Gao W., Thompson C.B. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001, 167:6869-6876.
141. Wofford J.A., Wieman H.L., Jacobs S.R., Zhao Y., Rathmell J.C. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 2008, 111:2101-2111.
142. Sinclair L.V., Finlay D., Feijoo C., Cornish G.H., Gray A., Ager A., et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 2008, 9:513-521.
143. Kerdiles Y.M., Beisner D.R., Tinoco R., Dejean A.S., Castrillon D.H., DePinho R.A., et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 2009, 10:176-184.
144. Carlson C.M., Endrizzi B.T., Wu J., Ding X., Weinreich M.A., Walsh E.R., et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 2006, 442:299-302.
145. Feng X., Wang H., Takata H., Day T.J., Willen J., Hu H. Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells. Nat Immunol 2011, 12:544-550.
146. Skon C.N., Jameson S.C. Fox factors fight over T cell quiescence. Nat Immunol 2011, 12:522-524.
147. Miller M.J., Wei S.H., Parker I., Cahalan M.D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002, 296:1869-1873.
148. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005, 23:127-159.
149. Bajenoff M., Egen J.G., Koo L.Y., Laugier J.P., Brau F., Glaichenhaus N., et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006, 25:989-1001.
150. Worbs T., Mempel T.R., Bolter J., von Andrian U.H., Forster R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007, 204:489-495.
151. Dummer W., Ernst B., LeRoy E., Lee D., Surh C. Autologous regulation of naive T cell homeostasis within the T cell compartment. J Immunol 2001, 166:2460-2468.
152. Dai Z., Lakkis F.G. Cutting edge: secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool. J Immunol 2001, 167:6711-6715.
153. Cinalli R.M., Herman C.E., Lew B.O., Wieman H.L., Thompson C.B., Rathmell J.C. T cell homeostasis requires G protein-coupled receptor-mediated access to trophic signals that promote growth and inhibit chemotaxis. Eur J Immunol 2005, 35:786-795.
154. Choi J., Oh S., Lee D., Oh H.J., Park J.Y., Lee S.B., et al. Mst1-FoxO signaling protects naive T lymphocytes from cellular oxidative stress in mice. PLoS ONE 2009, 4:e8011.
155. Katagiri K., Katakai T., Ebisuno Y., Ueda Y., Okada T., Kinashi T. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J 2009, 28:1319-1331.
156. Worbs T., Bernhardt G., Forster R. Factors governing the intranodal migration behavior of T lymphocytes. Immunol Rev 2008, 221:44-63.
157. Sanchez-Sanchez N., Riol-Blanco L., de la Rosa G., Puig-Kroger A., Garcia-Bordas J., Martin D., et al. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 2004, 104:619-625.
158. Kimura K., Matsubara H., Sogoh S., Kita Y., Sakata T., Nishitani Y., et al. Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. J Immunol 1991, 146:2618-2624.
159. Timmer T.C., Baltus B., Vondenhoff M., Huizinga T.W., Tak P.P., Verweij C.L., et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 2007, 56:2492-2502.
160. Yang B.G., Tanaka T., Jang M.H., Bai Z., Hayasaka H., Miyasaka M. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules: its implications in lymphocyte trafficking. J Immunol 2007, 179:4376-4382.
161. Stein J.V., Soriano S.F., M'Rini C., Nombela-Arrieta C., de Buitrago G.G., Rodriguez-Frade J.M., et al. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood 2003, 101:38-44.
162. Foxwell B.M., Beadling C., Guschin D., Kerr I., Cantrell D. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. Eur J Immunol 1995, 25:3041-3046.
163. Hofmeister R., Khaled A.R., Benbernou N., Rajnavolgyi E., Muegge K., Durum S.K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev 1999, 10:41-60.
164. Otero C., Groettrup M., Legler D.F. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J Immunol 2006, 177:2314-2323.
165. Britschgi M.R., Link A., Lissandrin T.K., Luther S.A. Dynamic modulation of CCR7 expression and function on naive T lymphocytes in vivo. J Immunol 2008, 181:7681-7688.
166. Xue H.H., Kovanen P.E., Pise-Masison C.A., Berg M., Radovich M.F., Brady J.N., et al. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc Natl Acad Sci U S A 2002, 99:13759-13764.
167. Mertsching E., Burdet C., Ceredig R. IL-7 transgenic mice: analysis of the role of IL-7 in the differentiation of thymocytes in vivo and in vitro. Int Immunol 1995, 7:401-414.
168. Boyman O., Ramsey C., Kim D.M., Sprent J., Surh C.D. IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia. J Immunol 2008, 180:7265-7275.
169. Sportes C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., Brown M.R., et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008, 205:1701-1714.
170. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 2001, 7:73-79.
171. Bolotin E., Annett G., Parkman R., Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999, 23:783-788.
172. Iwata M., Graf L., Awaya N., Torok-Storb B. Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein. Blood 2002, 100:1318-1325.
173. Martin C.E., Kim D.M., Sprent J., Surh C.D. Is IL-7 from dendritic cells essential for the homeostasis of CD4+ T cells?. Nat Immunol 2010, 11:547-548. author reply 548.
174. Scandella E., Bolinger B., Lattmann E., Miller S., Favre S., Littman D.R., et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol 2008, 9:667-675.
175. Estes J.D., Haase A.T., Schacker T.W. The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. Semin Immunol 2008, 20:181-186.
176. Saini M., Pearson C., Seddon B. Regulation of T cell-dendritic cell interactions by IL-7 governs T-cell activation and homeostasis. Blood 2009, 113:5793-5800.
177. Unsinger J., McGlynn M., Kasten K.R., Hoekzema A.S., Watanabe E., Muenzer J.T., et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010, 184:3768-3779.
178. Summers-DeLuca L.E., McCarthy D.D., Cosovic B., Ward L.A., Lo C.C., Scheu S., et al. Expression of lymphotoxin-alphabeta on antigen-specific T cells is required for DC function. J Exp Med 2007, 204:1071-1081.
179. Fry T.J., Christensen B.L., Komschlies K.L., Gress R.E., Mackall C.L. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 2001, 97:1525-1533.
180. Li J., Huston G., Swain S.L. IL-7 promotes the transition of CD4 effectors to persistent memory cells. J Exp Med 2003, 198:1807-1815.
181. Klonowski K.D., Williams K.J., Marzo A.L., Lefrancois L. Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development. J Immunol 2006, 177:4247-4251.
182. Lenz D.C., Kurz S.K., Lemmens E., Schoenberger S.P., Sprent J., Oldstone M.B., et al. IL-7 regulates basal homeostatic proliferation of antiviral CD4+ T cell memory. Proc Natl Acad Sci U S A 2004, 101:9357-9362.
183. Purton J.F., Tan J.T., Rubinstein M.P., Kim D.M., Sprent J., Surh C.D. Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med 2007, 204:951-961.
184. van Leeuwen E.M., Sprent J., Surh C.D. Generation and maintenance of memory CD4(+) T cells. Curr Opin Immunol 2009, 21:167-172.
185. Stonier S.W., Ma L.J., Castillo E.F., Schluns K.S. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. Blood 2008, 112:4546-4554.
186. Khanna K.M., McNamara J.T., Lefrancois L. In situ imaging of the endogenous CD8 T cell response to infection. Science 2007, 318:116-120.
187. Gardner J.M., Devoss J.J., Friedman R.S., Wong D.J., Tan Y.X., Zhou X., et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008, 321:843-847.
188. Sin J.I., Kim J., Pachuk C., Weiner D.B Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo. Clin Diagn Lab Immunol 2000, 7:751-758.
189. Calarota S.A., Dai A., Trocio J.N., Weiner D.B., Lori F., Lisziewicz J. IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine 2008, 26:5188-5195.
190. Nam H.J., Song M.Y., Choi D.H., Yang S.H., Jin H.T., Sung Y.C. Marked enhancement of antigen-specific T-cell responses by IL-7-fused nonlytic, but not lytic, Fc as a genetic adjuvant. Eur J Immunol 2010, 40:351-358.
191. Pellegrini M., Calzascia T., Elford A.R., Shahinian A., Lin A.E., Dissanayake D., et al. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat Med 2009, 15:528-536.
192. Kim M.Y., Gaspal F.M., Wiggett H.E., McConnell F.M., Gulbranson-Judge A., Raykundalia C., et al. CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity 2003, 18:643-654.
193. Kim S., Han S., Withers D.R., Gaspal F., Bae J., Baik S., et al. CD117 CD3 CD56 OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. Eur J Immunol 2011, 41:1563-1572.
194. Luther S.A., Bidgol A., Hargreaves D.C., Schmidt A., Xu Y., Paniyadi J., et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002, 169:424-433.
195. Lane P.J., McConnell F.M., Withers D., Gaspal F., Saini M., Anderson G. Lymphoid tissue inducer cells and the evolution of CD4 dependent high-affinity antibody responses. Prog Mol Biol Transl Sci 2010, 92:159-174.
196. Al-Rawi M.A., Watkins G., Mansel R.E., Jiang W.G. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int J Oncol 2005, 27:721-730.
197. Gorelik L., Gilbride K., Dobles M., Kalled S.L., Zandman D., Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003, 198:937-945.
198. Berney C., Herren S., Power C.A., Gordon S., Martinez-Pomares L., Kosco-Vilbois M.H. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J Exp Med 1999, 190:851-860.
199. Pound J.D., Gordon J. Maintenance of human germinal center B cells in vitro. Blood 1997, 89:919-928.
200. Kitano M., Moriyama S., Ando Y., Hikida M., Mori Y., Kurosaki T., et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 2011, 34:961-972.
201. Cooper C.J., Turk G.L., Sun M., Farr A.G., Fink P.J. Cutting edge: TCR revision occurs in germinal centers. J Immunol 2004, 173:6532-6536.
202. Zheng B., Xue W., Kelsoe G. Locus-specific somatic hypermutation in germinal centre T cells. Nature 1994, 372:556-559.
203. Fletcher A.L., Malhotra D., Turley S.J. Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol 2011, 32:12-18.
204. Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006, 6:205-217.
205. Drayton D.L., Liao S., Mounzer R.H., Ruddle N.H. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 2006, 7:344-353.
206. Link A., Hardie D.L., Favre S., Britschgi M.R., Adams D.H., Sixt M., et al. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am J Pathol 2011, 178:1662-1675.
207. Carragher D.M., Rangel-Moreno J., Randall T.D. Ectopic lymphoid tissues and local immunity. Semin Immunol 2008, 20:26-42.
208. Finke D., Schmutz S. Interleukin 7-induced lymphoid neogenesis in arthritis: recapitulation of a fetal developmental programme. Swiss Med Wkly 2008, 138:500-505.
209. Wengner A.M., Hopken U.E., Petrow P.K., Hartmann S., Schurigt U., Brauer R., et al. CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum 2007, 56:3271-3283.
210. Cupedo T., Jansen W., Kraal G., Mebius R.E. Induction of secondary and tertiary lymphoid structures in the skin. Immunity 2004, 21:655-667.
211. Schneider K., Potter K.G., Ware C.F. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 2004, 202:49-66.
212. Marinkovic T., Garin A., Yokota Y., Fu Y.X., Ruddle N.H., Furtado G.C., et al. Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest 2006, 116:2622-2632.
213. Halle S., Dujardin H.C., Bakocevic N., Fleige H., Danzer H., Willenzon S., et al. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J Exp Med 2009, 206:2593-2601.
214. GeurtsvanKessel C.H., Willart M.A., Bergen I.M., van Rijt L.S., Muskens F., Elewaut D., et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009, 206:2339-2349.
215. Hartgring S.A., Bijlsma J.W., Lafeber F.P., van Roon J.A. Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis 2006, 65(Suppl 3):iii69-iii74.
216. Hartgring S.A., Willis C.R., Alcorn D., Nelson L.J., Bijlsma J.W., Lafeber F.P., et al. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis Rheum 2010, 62:2716-2725.
217. Watanabe M., Ueno Y., Yajima T., Okamoto S., Hayashi T., Yamazaki M., et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 1998, 187:389-402.
218. Uehira M., Matsuda H., Hikita I., Sakata T., Fujiwara H., Nishimoto H. The development of dermatitis infiltrated by gamma delta T cells in IL-7 transgenic mice. Int Immunol 1993, 5:1619-1627.
219. Yamazaki M., Yajima T., Tanabe M., Fukui K., Okada E., Okamoto R., et al. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J Immunol 2003, 171:1556-1563.
220. van Roon J.A., Verweij M.C., Wijk M.W., Jacobs K.M., Bijlsma J.W., Lafeber F.P. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum 2005, 52:1700-1710.
221. Pickens S.R., Chamberlain N.D., Volin M.V., Pope R.M., Talarico N.E., Mandelin A.M., et al. Characterization of IL-7 and IL-7R in the pathogenesis of Rheumatoid Arthritis. Arthritis Rheum 2011, 63:2884-2893.
222. van Roon J.A., Hartgring S.A., Wenting-van Wijk M., Jacobs K.M., Tak P.P., Bijlsma J.W., et al. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:664-669.
223. Hartgring S.A., Willis C.R., Dean C.E., Broere F., van Eden W., Bijlsma J.W., et al. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis Rheum 2011, 63:1878-1887.
224. Shochat C., Tal N., Bandapalli O.R., Palmi C., Ganmore I., te Kronnie G., et al. Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med 2011, 208:901-908.
225. Zenatti P.P., Ribeiro D., Li W., Zuurbier L., Silva M.C., Paganin M., et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 2011, 43:932-939.
226. Yamaoka K., Min B., Zhou Y.J., Paul W.E., O'Shea J.J. Jak3 negatively regulates dendritic-cell cytokine production and survival. Blood 2005, 106:3227-3233.
227. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
228. Adachi S., Yoshida H., Honda K., Maki K., Saijo K., Ikuta K., et al. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int Immunol 1998, 10:1-6.
229. Hand T.W., Morre M., Kaech S.M. Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc Natl Acad Sci U S A 2007, 104:11730-11735.